Save your screen. Keep the bounds you have set, and get an email when an insider trades at a company it holds. A free account does both.
| Stock | FY | Clue Score ↓ | Market cap ↓ | Stock price ↓ | % change ↓ | PE ratio ↓ | Return on invested capital ↓ | Revenue growth 3Y ↓ | Net margin ↓ | Insider buyers 12M ↓ |
|---|---|---|---|---|---|---|---|---|---|---|
| DNTHDianthus Therapeutics, Inc. /DE/ | 2025 | 31 | $4.61B | $82.37 | -0.07% | — | -28.49% | -31.80% | -7,973.33% | 0 |